vs
Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and Ceribell, Inc. (CBLL). Click either name above to swap in a different company.
ADAMAS TRUST, INC. is the larger business by last-quarter revenue ($43.2M vs $24.8M, roughly 1.7× Ceribell, Inc.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -54.6%, a 178.6% gap on every dollar of revenue. ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
ADAM vs CBLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.2M | $24.8M |
| Net Profit | $53.5M | $-13.5M |
| Gross Margin | — | 87.3% |
| Operating Margin | — | -58.9% |
| Net Margin | 124.0% | -54.6% |
| Revenue YoY | 61.6% | — |
| Net Profit YoY | 270.5% | — |
| EPS (diluted) | $0.45 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.2M | $24.8M | ||
| Q3 25 | $36.6M | $22.6M | ||
| Q2 25 | $36.4M | $21.2M | ||
| Q1 25 | $33.1M | $20.5M | ||
| Q4 24 | $26.7M | — | ||
| Q3 24 | $20.2M | $17.2M | ||
| Q2 24 | $19.0M | — | ||
| Q1 24 | $17.9M | — |
| Q4 25 | $53.5M | $-13.5M | ||
| Q3 25 | $44.8M | $-13.5M | ||
| Q2 25 | $8.5M | $-13.6M | ||
| Q1 25 | $42.2M | $-12.8M | ||
| Q4 24 | $-31.4M | — | ||
| Q3 24 | $42.8M | $-10.4M | ||
| Q2 24 | $-15.6M | — | ||
| Q1 24 | $-57.9M | — |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 88.3% | ||
| Q2 25 | — | 88.1% | ||
| Q1 25 | — | 87.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 87.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -58.9% | ||
| Q3 25 | — | -64.8% | ||
| Q2 25 | 11.7% | -70.5% | ||
| Q1 25 | — | -69.3% | ||
| Q4 24 | -119.0% | — | ||
| Q3 24 | — | -57.8% | ||
| Q2 24 | -124.7% | — | ||
| Q1 24 | -448.8% | — |
| Q4 25 | 124.0% | -54.6% | ||
| Q3 25 | 122.5% | -59.6% | ||
| Q2 25 | 23.4% | -64.4% | ||
| Q1 25 | 127.4% | -62.4% | ||
| Q4 24 | -117.5% | — | ||
| Q3 24 | 211.7% | -60.6% | ||
| Q2 24 | -81.9% | — | ||
| Q1 24 | -324.1% | — |
| Q4 25 | $0.45 | $-0.35 | ||
| Q3 25 | $0.36 | $-0.37 | ||
| Q2 25 | $-0.04 | $-0.38 | ||
| Q1 25 | $0.33 | $-0.36 | ||
| Q4 24 | $-0.46 | — | ||
| Q3 24 | $0.36 | $-1.85 | ||
| Q2 24 | $-0.29 | — | ||
| Q1 24 | $-0.75 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.3M | $159.3M |
| Total DebtLower is stronger | $735.8M | — |
| Stockholders' EquityBook value | $1.4B | $155.3M |
| Total Assets | $12.6B | $195.8M |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.3M | $159.3M | ||
| Q3 25 | $185.3M | $168.5M | ||
| Q2 25 | $160.4M | $177.4M | ||
| Q1 25 | $177.1M | $182.7M | ||
| Q4 24 | $167.4M | — | ||
| Q3 24 | $195.1M | $14.1M | ||
| Q2 24 | $235.5M | — | ||
| Q1 24 | $226.9M | — |
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | — |
| Q4 25 | $1.4B | $155.3M | ||
| Q3 25 | $1.4B | $164.1M | ||
| Q2 25 | $1.4B | $172.2M | ||
| Q1 25 | $1.4B | $180.9M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | $-136.0M | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $12.6B | $195.8M | ||
| Q3 25 | $12.4B | $199.5M | ||
| Q2 25 | $10.6B | $207.7M | ||
| Q1 25 | $10.0B | $213.5M | ||
| Q4 24 | $9.2B | — | ||
| Q3 24 | $8.9B | $47.1M | ||
| Q2 24 | $8.2B | — | ||
| Q1 24 | $7.4B | — |
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.0M | $-10.8M |
| Free Cash FlowOCF − Capex | $125.9M | $-11.0M |
| FCF MarginFCF / Revenue | 291.6% | -44.2% |
| Capex IntensityCapex / Revenue | 18.9% | 0.7% |
| Cash ConversionOCF / Net Profit | 2.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-41.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.0M | $-10.8M | ||
| Q3 25 | $6.9M | $-11.1M | ||
| Q2 25 | $39.2M | $-7.5M | ||
| Q1 25 | $25.8M | $-11.4M | ||
| Q4 24 | $14.1M | — | ||
| Q3 24 | $-922.0K | — | ||
| Q2 24 | $-993.0K | — | ||
| Q1 24 | $-13.1M | — |
| Q4 25 | $125.9M | $-11.0M | ||
| Q3 25 | — | $-11.5M | ||
| Q2 25 | — | $-7.6M | ||
| Q1 25 | — | $-11.6M | ||
| Q4 24 | $-10.6M | — | ||
| Q3 24 | $-8.6M | — | ||
| Q2 24 | $-8.6M | — | ||
| Q1 24 | $-19.1M | — |
| Q4 25 | 291.6% | -44.2% | ||
| Q3 25 | — | -50.8% | ||
| Q2 25 | — | -35.9% | ||
| Q1 25 | — | -56.4% | ||
| Q4 24 | -39.6% | — | ||
| Q3 24 | -42.3% | — | ||
| Q2 24 | -44.9% | — | ||
| Q1 24 | -107.0% | — |
| Q4 25 | 18.9% | 0.7% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 92.3% | — | ||
| Q3 24 | 37.7% | — | ||
| Q2 24 | 39.7% | — | ||
| Q1 24 | 33.5% | — |
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 4.59× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
